Kindler’s Honeymoon Over? Analysts Press Pfizer Execs On Series Of Stumbles
Executive Summary
The sheen of Pfizer's new management team - including CEO Jeffrey Kindler - may be beginning to wear off, based on analyst comments during Pfizer's April 20 first-quarter earnings call